RARA CRAFT DATABASE for FDA Medical Devices
510(k)K203358

FDA DEVICE FACTS

Solitaire X Revascularization Device

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEMarch 1, 2021PRODUCT CODEPOL

Indications for use

1. The Solitaire ™ X Revascularization D evice is indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients wi th a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (I V t-PA). Endova scular therapy with the device should be started within 6 hours of symptom o nset. 2. The Solitaire ™ X Revascularization D evice is indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for I V t-P A or who fail IV t-P A therapy are candidates for treatment. 3. The Solitaire ™ X Revascularization D evice is indicated for use to restore blood flow in the neurova sculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients wi th a persistent, proximal anterior circulation, large vessel occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA)-Ml segments with smaller core infarcts (< 70 cc by CTA or MRA, < 25 cc by MR-DWI). Endova scular therapy with the device should start within 6-16 hours of time last seen well in patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail I V t-PA therapy.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026